American Heart Association Rapid Access Journal Report: Poor Countries Have Disproportionately Higher Burden of Disease From Stroke Than From Heart Disease

Chicago, Illinois, UNITED STATES

Study Highlights:

  • Poorer countries often have disproportionately higher rates of stroke disability and death than wealthier countries.
  • The study authors suggest stroke and heart disease rates may need to be considered separately for global disease reporting and prevention efforts.

DALLAS, July 5, 2011 (GLOBE NEWSWIRE) -- Countries with lower national income have disproportionately higher rates of death and disability associated with stroke compared with ischemic heart disease, according to a study published in Circulation: Journal of the American Heart Association.

Together, ischemic heart disease and stroke are the two leading causes of death worldwide. Ischemic heart disease accounts for 12.2 percent of all deaths and stroke for 9.7 percent, according to the World Health Organization (WHO) Global Burden of Disease Program.

But the relative rates of death and disability from heart disease and stroke vary considerably from country to country.

For example, "In the United States, heart disease is still the No. 1 cause of death, but stroke recently went from No. 3 to No. 4 (according to CDC data)," said Anthony S. Kim, M.D., co-author of the study and assistant professor of neurology at the University of California, San Francisco. "Whereas, in China, WHO data shows the situation is nearly reversed — they are facing an epidemic of cerebrovascular disease, and stroke is the leading cause of death."

From WHO data on death rates and disease burden, Kim and co-author S. Claiborne Johnston, M.D., Ph.D., found that stroke death rates exceeded heart disease death rates in 74 of 192 countries (nearly 40 percent). In 62 countries (nearly one-third), the burden of disease from stroke — measured in disability adjusted life year (DALY) loss rates — also surpassed that of heart disease.

The Pacific island republic of Kiribati topped both lists with a death rate and a disease burden from stroke about 11 times higher than mortality and disease burden from ischemic heart disease.

At the other end of the scale, Azerbaijan had a mortality rate from ischemic heart disease three times that from stroke, and Turkmenistan had a disease burden from ischemic heart disease more than five times that from stroke.

In general, stroke death rates and disease burden appeared to be disproportionately higher than those for ischemic heart disease in African and Asian countries, while they were lower in North American, Western and Northern European countries, and Australia.

"At first, one might think that this is simply a reflection of the different patterns of risk factors operating in different countries, but it is actually much more complicated than that," Kim said.

Traditional risk factors, such as diabetes and high cholesterol, were associated with greater death and disease burden from ischemic heart disease. However, low national income was strongly associated with a higher relative death and disease burden from stroke, according to this analysis of WHO and World Bank data.

"Researchers and policy makers often think of stroke and heart disease together when designing cardiovascular disease prevention programs. But there may be important reasons to consider the two separately as well," Kim said.

For example, if a country has three times the disease burden from stroke than it does from heart disease, one could imagine a situation where a broad-based intervention to tackle cardiovascular disease more generally might not have as much impact as a program specifically targeting extremely high blood pressure, since this is a much more potent risk factor for stroke than for heart disease.

"Ultimately, the goal is to better understand the reasons behind these differences in order to develop interventions to address the specific issues in a particular country," Kim said.

While this study was unfunded, Dr. Kim is supported by American Heart Association grants in other areas of study. Full disclosure information is on the manuscript.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events.  The association has strict policies to prevent these relationships from influencing the science content.  Revenues from pharmaceutical and device corporations are available at

NR11 – 1092 (Circ/Kim)

Additional resources:

  The American Heart Association logo is available at


Contact Data